Physician profile
Ian Patrick Jackson
NPI 1326602459
$2,213.18
in general payments reported to CMS, 2019-2025
21 companies · $1,359 in 2025
The $1,359 reported for 2025 was more than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $30.63 · 2023: $122 · 2024: $701 · 2025: $1,359.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,164 · Education: $18.85.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,163.70 |
| Education | $18.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $740.95 | 2023-2025 | Fasenra, Breztri, Tezspire |
| United Therapeutics Corporation | $548.53 | 2024-2025 | Tyvaso, Tyvaso |
| Merck Sharp & Dohme LLC | $177.62 | 2025 | Winrevair |
| Insmed, INC. | $117.58 | 2025 | Arikayce, Brinsupri |
| Jazz Pharmaceuticals INC. | $106.24 | 2024-2025 | |
| Amgen INC. | $72.95 | 2024 | Tezspire |
| Boehringer Ingelheim Pharmaceuticals, INC. | $61.27 | 2024-2025 | Ofev |
| Glaxosmithkline, LLC. | $46.99 | 2024-2025 | Nucala |
| Electromed, INC. | $41.70 | 2025 | Smartvest |
| Genzyme Corporation | $39.30 | 2025 | |
| Viatris Specialty LLC | $33.06 | 2025 | Yupelri |
| Abiomed | $30.86 | 2024 | Impella |
| Bayer Healthcare Pharmaceuticals INC. | $30.63 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $24.36 | 2025 | Glassia |
| Harmony Biosciences LLC | $23.93 | 2025 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Liquidia Technologies, INC. | $22.91 | 2025 | Yutrepia |
| Getinge USA Sales, LLC | $20.89 | 2025 | Vasoview Hemopro 2 |
| Baxter Healthcare | $20.84 | 2025 | Hillrom - Vest System Model 105 Home Care |
| Alexion Pharmaceuticals, INC. | $19.40 | 2024 | Ultomiris |
| Avadel Cns Pharmaceuticals, LLC | $18.97 | 2025 | Lumryz |
| Philips North America LLC | $14.20 | 2025 | Vest Therapy Und |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ian Jackson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.